Cargando…
Benzoylaconitine Alleviates Progression of Psoriasis via Suppressing STAT3 Phosphorylation in Keratinocytes
Psoriasis is a chronic and multifactorial skin disease which is caused by inflammatory infiltrates, keratinocyte hyperproliferation, and accumulation of immune cells. As part of the Aconitum species, Benzoylaconitine (BAC) shows potential antiviral, anti-tumor, and anti-inflammatory effects. In this...
Autores principales: | Li, Yuanbo, Guo, Dandan, Wang, Qianqian, Li, Aifang, Yin, Sugai, Li, Shuxuan, Li, Yalan, Wang, Baiyan, Guo, Tao, Feng, Shuying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10254579/ https://www.ncbi.nlm.nih.gov/pubmed/37298949 http://dx.doi.org/10.3390/molecules28114473 |
Ejemplares similares
-
Strategies for High-Efficiency Mutation Using the CRISPR/Cas System
por: Feng, Shuying, et al.
Publicado: (2022) -
A Novel Modulator of the Renin–Angiotensin System, Benzoylaconitine, Attenuates Hypertension by Targeting ACE/ACE2 in Enhancing Vasodilation and Alleviating Vascular Inflammation
por: Zhang, Qi-Qiang, et al.
Publicado: (2022) -
A potential paradigm in CRISPR/Cas systems delivery: at the crossroad of microalgal gene editing and algal-mediated nanoparticles
por: Feng, Shuying, et al.
Publicado: (2023) -
Curcumol may alleviate psoriasis-like inflammation by inhibiting keratinocyte proliferation and inflammatory gene expression via JAK1/STAT3 signaling
por: Lv, Mingfen, et al.
Publicado: (2021) -
Current and prospective strategies for advancing the targeted delivery of CRISPR/Cas system via extracellular vesicles
por: Huang, Xiaowen, et al.
Publicado: (2023)